QUINOLINE AND ISOQUINOLINE DERIVATIVES FOR USE AS JAK MODULATORS
申请人:Faraoni Raffaella
公开号:US20130296363A1
公开(公告)日:2013-11-07
Provided herein are compounds for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma
作者:David E. Uehling、Babu Joseph、Kim Chan Chung、Andrew X. Zhang、Spencer Ler、Michael A. Prakesch、Gennady Poda、Julie Grouleff、Ahmed Aman、Taira Kiyota、Chungyee Leung-Hagesteijn、John David Konda、Richard Marcellus、Carly Griffin、Ratheesh Subramaniam、Ayome Abibi、Craig A. Strathdee、Methvin B. Isaac、Rima Al-awar、Rodger E. Tiedemann